The overview is presented of our own studies showing the importance of including the endotoxins and other components of microbiome and nanobiota of the lungs and airways, gut and other sources to the concepts of phylo- and ontogenetic bioregulation.

Keywords: Microbiome; Ontogeny; Lipopolysaccharide; Endotoxins

1. Goudochnikov VI and Barbosa AMO. “[Considerations in psycho-neuro-endocrin-immunology (PNEI) of the role of bacteriomodulins and cytokines in the induction of seakness status: Possible dependence on patient age, circadian biorhythms and interactions of hormones with infectious agents]”. In: 1. Jornada de Psicologia da UFSM. Santa Maria – RS, (Abstract, in Portuguese) (1997): 11.
2. Goudochnikov VI. “[Phenomena of programming/imprinting in neuroimmunology: The role of endotoxins in development and aging]”. Advances in Gerontology (St. Petersburg) 5 (2024): 603-604.
3. Goudochnikov VI. “Central positions of glucocorticoids and stress in the phenomena of hormonal and metabolic programming/imprinting”. Journal of Endocrinological Science1 (2023): 1-7.
4. Goudochnikov VI. “Age-related changes in the liver: On the way to ontogenetic bioregulation”. Gastroenterology Medicine and Research3 (2026): 757-759.
5. Goudochnikov VI. “Endocrinology and gerontology: Disciplines that need the broadening and expansion”. Journal of Endocrinology and Diabetes Research1 (2024): 1-4.
6. Goudochnikov VI. “Phylo- and ontopathogenic models: Relation to gerontology and endocrinology”. WebLog Journal of Gerontology and Geriatrics (2026): e1802.
7. Goudochnikov VI. “[The phenomena of programming and imprinting in neuroimmunology: Roles of endotoxins and microbiome in development and aging]”. In: Proceedings of MOIP: Collection of Articles from the Gerontology Section. Toronto: Longevity Books (2025): 86-90.
8. Goudochnikov VI. “The contribution of stress and its mediators to the ontopathogeny of infections: A focus on the interactions of cytokines and glucocorticoids”. Advances in Gerontology (St. Petersburg) 7 (2017): 25-28.
9. Dalmora SL., et al. “Prepubertal lymphocytopenia and thymus suppression accompany growth inhibition induced by neonatal glucocorticoid treatment”. Revista Argentina de Endocrinologia y Metabolismo 31 (1994): 36.
10. Goudochnikov VI. “Perinatal treatment of some respiratory disorders with glucocorticoids in relation to prematurity”. EC Pulmonology and Respiratory Medicine1 (2017): 23-27.
11. Goudochnikov VI. “Glucocorticoid-induced growth inhibition: An update”. Open Access Journal of Endocrinology1 (2022): 165.
12. Goudochnikov VI. “Pharmacotherapy of pulmonary and other disorders: The importance of age-related considerations focusing on corticosteroids”. EC Pulmonology and Respiratory Medicine4 (2026): 1-3.
13. Goudochnikov VI. “Non-respiratory pulmonary functions: Focusing on bioregulation in a broader sense”. EC Pulmonology and Respiratory Medicine2 (2025): 1-2.
14. Goudochnikov VI. “Tissue streaming in the lungs and airways: What are its ontogenetic alterations?” EC Pulmonology and Respiratory Medicine11 (2025): 1-2.
15. Goudochnikov VI. “Gap-junctional intercellular communication in the lungs and airways: An underscored direction of research”. EC Pulmonology and Respiratory Medicine 2 (2026): 1-3.
16. Goudochnikov VI. “Exosomics as new perspective for pulmonary disorders and ontogenetic bioregulation”. EC Pulmonology and Respiratory Medicine9 (2026): 1-3.